ES2057126T3 - Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo. - Google Patents
Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo.Info
- Publication number
- ES2057126T3 ES2057126T3 ES89306147T ES89306147T ES2057126T3 ES 2057126 T3 ES2057126 T3 ES 2057126T3 ES 89306147 T ES89306147 T ES 89306147T ES 89306147 T ES89306147 T ES 89306147T ES 2057126 T3 ES2057126 T3 ES 2057126T3
- Authority
- ES
- Spain
- Prior art keywords
- hydrogen
- alkyl
- halogen
- caquexia
- new compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Storage Of Fruits Or Vegetables (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
COMPUESTOS DE FORMULA(I), DONDE Y ES UN GRUPO DE FORMULA(III), SIENDO LA LINEA PESPUNTEADA UN ENLACE DOBLE O SENCILLO; R1 ES H, ALQUILO O ARILO; R2 ES H O HALOGENO; R3 ES ALQUILO O CICLOALQUILO; R4 ES H, ALQUILO, HIDROXI, O O HALOGENO; Y R6 ES H, ALQUILO OPCIONALMENTE SUSTITUIDO O ALQUENILO, ALQUINILO, CICLOALQUILO, ARILO O ARALQUILO; Y SUS SALES FARMACEUTICAMENTE ACEPTABLES SON VALIDAD EN EL TRATAMIENTO, ALIVIO Y PROFILAXIS DE CAUQEXIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14913788 | 1988-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2057126T3 true ES2057126T3 (es) | 1994-10-16 |
Family
ID=15468558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89306147T Expired - Lifetime ES2057126T3 (es) | 1988-06-16 | 1989-06-16 | Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo. |
Country Status (9)
Country | Link |
---|---|
US (2) | US5055479A (es) |
EP (2) | EP0347252B1 (es) |
JP (1) | JPH0276880A (es) |
KR (1) | KR910000737A (es) |
AT (2) | ATE88894T1 (es) |
CA (1) | CA1329199C (es) |
DE (2) | DE68922408D1 (es) |
ES (1) | ES2057126T3 (es) |
IE (2) | IE930392L (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1330079C (en) * | 1988-10-13 | 1994-06-07 | Michihiko Tsujitani | Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same |
US5264220A (en) * | 1991-11-12 | 1993-11-23 | Long David M Jr | Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
JPH10218881A (ja) * | 1997-02-03 | 1998-08-18 | Pola Chem Ind Inc | 新規なピロロピラゾロピリミジン誘導体 |
TWI271406B (en) | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
US20020061897A1 (en) | 2000-03-30 | 2002-05-23 | Elliott Richard L. | Neuropeptide Y antagonists |
JP2002043785A (ja) | 2000-07-28 | 2002-02-08 | Murata Mfg Co Ltd | シールドケース及びそれを用いた電子機器及びそれを用いた電子装置及びシールドケースの製造方法 |
DZ3415A1 (fr) | 2000-08-31 | 2002-03-07 | Chiron Corp | Guanidinobenzamides comme mc4-r agonistes. |
EP1767525A1 (en) | 2001-04-09 | 2007-03-28 | Novartis Vaccines and Diagnostics, Inc. | Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists |
DK1433480T3 (da) | 2001-07-13 | 2011-04-11 | Btg Internat Ltd Company | Lægemiddel indeholdende pyrimidin-derivat |
US20030207814A1 (en) * | 2002-02-04 | 2003-11-06 | Chiron Corporation | Novel guanidinyl derivatives |
US20050124652A1 (en) * | 2002-02-04 | 2005-06-09 | Rustum Boyce | Guanidino compounds |
US20030195187A1 (en) * | 2002-02-04 | 2003-10-16 | Chiron Corporation | Guanidino compounds |
WO2003072056A2 (en) * | 2002-02-25 | 2003-09-04 | Chiron Corporation | Intranasal administration of mc4-r agonists |
MXPA04011557A (es) * | 2002-05-23 | 2005-07-05 | Chiron Corp | Compuestos de quinazolinona sustituida. |
US7051505B2 (en) * | 2002-08-21 | 2006-05-30 | Greg Brannstrom | Tomato harvester |
US7329658B2 (en) * | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
US7176210B2 (en) * | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
JP2007501861A (ja) * | 2003-05-23 | 2007-02-01 | カイロン コーポレイション | Mc4−rアゴニストとしてのグアニジノ置換キナゾリノン化合物 |
US20050009919A1 (en) * | 2003-07-07 | 2005-01-13 | Clouatre Dallas L. | Treating cachexia and excessive catabolism with (-)-hydroxycitric acid |
MXPA06005736A (es) * | 2003-11-19 | 2006-12-14 | Chiron Corp | Compuestos de quinazolinona con bioacumulacion reducida. |
US8257684B2 (en) * | 2008-03-26 | 2012-09-04 | Neurosigma, Inc. | Methods for identifying and targeting autonomic brain regions |
KR101601994B1 (ko) | 2008-04-15 | 2016-03-17 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 3-페닐피라졸로[5,1-b]티아졸 화합물 |
GB0917774D0 (en) | 2009-10-09 | 2009-11-25 | Senexis Ltd | Novel pharmaceutical compounds |
GB0917775D0 (en) | 2009-10-09 | 2009-11-25 | Btg Int Ltd | Novel pharmaceutical compounds |
WO2012027239A1 (en) * | 2010-08-23 | 2012-03-01 | Schering Corporation | NOVEL PYRAZOLO[1,5-a]PYRROLO[3,2-e]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
KR20160101398A (ko) | 2015-02-17 | 2016-08-25 | 순천대학교 산학협력단 | 바륨타이타네이트층을 포함하는 복합 세라믹 전극의 제조방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51141896A (en) * | 1975-05-31 | 1976-12-07 | Sankyo Co Ltd | Process for preparing fused ring triazoropyrimidine derivatives |
DE2704030A1 (de) * | 1976-02-12 | 1977-08-18 | Sandoz Ag | Neue organische verbindungen, ihre herstellung und verwendung |
JPS5353697A (en) * | 1976-10-20 | 1978-05-16 | Sankyo Co Ltd | Tricyclic triazolopyrimidine derivatives |
US4619933A (en) * | 1979-09-28 | 1986-10-28 | The Upjohn Company | 6-aryl pyrimidines for treating aplastic anemia |
JPS5735593A (en) * | 1980-08-12 | 1982-02-26 | Mochida Pharmaceut Co Ltd | Novel pyrolo 3,2-e -s-triazolo 1,5-a pyrimidine derivative |
EP0101517B1 (en) * | 1982-02-19 | 1986-10-29 | Mochida Pharmaceutical Co., Ltd. | Novel s-triazole(1,5-a)pyrimidine derivatives |
CA1330079C (en) * | 1988-10-13 | 1994-06-07 | Michihiko Tsujitani | Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same |
-
1989
- 1989-06-14 JP JP1149578A patent/JPH0276880A/ja active Pending
- 1989-06-14 US US07/365,851 patent/US5055479A/en not_active Expired - Fee Related
- 1989-06-16 DE DE68922408T patent/DE68922408D1/de not_active Expired - Lifetime
- 1989-06-16 CA CA000603102A patent/CA1329199C/en not_active Expired - Fee Related
- 1989-06-16 EP EP89306147A patent/EP0347252B1/en not_active Expired - Lifetime
- 1989-06-16 EP EP92201695A patent/EP0508549B1/en not_active Expired - Lifetime
- 1989-06-16 DE DE89306147T patent/DE68906309T2/de not_active Expired - Fee Related
- 1989-06-16 ES ES89306147T patent/ES2057126T3/es not_active Expired - Lifetime
- 1989-06-16 AT AT89306147T patent/ATE88894T1/de active
- 1989-06-16 AT AT92201695T patent/ATE121744T1/de not_active IP Right Cessation
- 1989-06-16 IE IE930392A patent/IE930392L/xx unknown
- 1989-06-16 IE IE196389A patent/IE62915B1/en not_active IP Right Cessation
- 1989-06-16 KR KR1019890008349A patent/KR910000737A/ko not_active Application Discontinuation
-
1991
- 1991-04-25 US US07/691,542 patent/US5086057A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5086057A (en) | 1992-02-04 |
ATE88894T1 (de) | 1993-05-15 |
IE62915B1 (en) | 1995-03-08 |
KR910000737A (ko) | 1991-01-30 |
EP0508549B1 (en) | 1995-04-26 |
CA1329199C (en) | 1994-05-03 |
JPH0276880A (ja) | 1990-03-16 |
EP0347252B1 (en) | 1993-05-05 |
DE68922408D1 (de) | 1995-06-01 |
IE891963L (en) | 1989-12-16 |
EP0347252A2 (en) | 1989-12-20 |
DE68906309T2 (de) | 1994-01-05 |
EP0508549A2 (en) | 1992-10-14 |
EP0347252A3 (en) | 1991-03-27 |
EP0508549A3 (en) | 1992-11-25 |
US5055479A (en) | 1991-10-08 |
ATE121744T1 (de) | 1995-05-15 |
IE930392L (en) | 1989-12-16 |
DE68906309D1 (de) | 1993-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2057126T3 (es) | Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo. | |
DK0632036T3 (da) | Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser | |
ATE103812T1 (de) | Zusammensetzung zur behandlung von ischaemischen stoerungen in organen. | |
ATE79257T1 (de) | Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
AU2868689A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
ATE92316T1 (de) | Verwendung von l-carnitinderivaten zur herstellung eines arzneimittels zur therapeutischen behandlung von peripheren neuropathien. | |
ATE121395T1 (de) | Cumarinderivate, ihre herstellung und ihre verwendung zur behandlung von zerebrovaskulären störungen. | |
ATE100077T1 (de) | 2-hydroxy-3-phenoxypropylaminoverbindungen. | |
HUT44767A (en) | Process for producing new spiro-imidazolidine derivatives | |
EP0285284A3 (en) | N-phenethylaminoalkyl-benzamide anti-arrhythmia agents | |
NO173991C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater | |
ZA927307B (en) | Method for treating hypertension | |
ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
DE3882956D1 (de) | Gegen die zerebrale insuffizienz wirksame verbindungen. | |
ATE111462T1 (de) | 1,4-dihydropyridin-derivate. | |
ES2037825T3 (es) | Uso farmaceutico de tioeteres aromaticos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 347252 Country of ref document: ES |